Table 1.
Clinical characteristics of the COVID-19 patient cohort.
| Characteristics | Asymptomatic/ Mild (N = 69) |
Moderate (N = 67) |
Severe/Fatal (N = 64) |
|---|---|---|---|
| Concomitant disease | |||
| No comorbidity | 57 | 53 | 14 |
| Diabetes | 1 | 2 | 8 |
| Hypertension | 0 | 1 | 13 |
| Dyslipidemia | 0 | 1 | 0 |
| Kidney disease | 1 (Acute glomerulonephritis) |
1 (Addison’s disease) | 7 |
| Cardiovascular disease | 2 | 0 | 3 |
| Lung disease | 0 | 02 (Bronchial asthma, COPD) |
1 (COPD) |
| Liver disease | 0 | 0 | 3 |
| Thyroid disease | 0 | 0 | |
| Anemia | 1 | 0 | |
| Cancer | 0 | 2 (lung cancer, breast cancer) |
11 |
| Clinical symptoms | |||
| Fever | 4 | 10 | 42 |
| Cough | 19 | 26 | 39 |
| Shortness of breath | 1 | 3 | 60 |
N: Number of subjects; COPD: Chronic Obstructive Pulmonary Disease.